Stocky turns companies like COSMO BIO COMPANY LIMITED into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 3386.T shows modest fundamentals (Growth Compounder 33.5, Value Compounder 43) with middling Leadership Alignment (59/100), suggesting neither compelling growth momentum nor valuation tailwinds. The Vulnerability Index of 100 indicates material business or structural risks that are not yet fully characterized, warranting careful monitoring before committing capital.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for COSMO BIO COMPANY LIMITED:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 53/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates COSMO BIO COMPANY LIMITED (3386.T) at 53/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 3386.T shows modest fundamentals (Growth Compounder 33.5, Value Compounder 43) with middling Leadership Alignment (59/100), suggesting neither compelling growth momentum nor valuation tailwinds. The Vulnerability Index of 100 indi
3386.T's current Stocky Verdict is 53/100, placing it in the "Cautious" band. This composite combines a 43/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for COSMO BIO COMPANY LIMITED yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
COSMO BIO COMPANY LIMITED scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
COSMO BIO COMPANY LIMITED's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to COSMO BIO COMPANY LIMITED.
Sign up free and unlock the full analysis on 3386.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 3386.T in the app.
